期刊文献+

VEGF对创伤组织中KDR,bFGF和PDGF mRNA表达的影响 被引量:7

The effect of VEGF to the expression of KDR, bFGF and PDGF mRNA in the wounded tissue
暂未订购
导出
摘要 目的研究VEGF对创伤组织KDR,bFGF和PDGFmRNA表达的影响,探讨其促进损伤组织修复的作用机理。方法以血管内皮细胞生长因子(VEGF165)为目的基因,构建真核表达载体pcDNA3.1/myc-hisA-VEGF165,利用纳米微囊包裹后,作用于兔耳创面。利用反转录PCR方法观察术后14天损伤组织KDR,bFGF和PDGFmRNA的表达变化。结果施与纳米微囊包裹的VEGF165实验组创面肉芽生长及上皮爬行速度明显快于对照组。反转录PCR的结果显示实验组损伤组织KDR,bFGF和PDGFmRNA的表达水平明显高于对照组(P<0.05)及正常组(P<0.01)。结论VEGF能上调损伤组织内KDR,bFGF和PDGFmRNA的表达,VEGF可能作用于其受体KDR,通过与其他细胞因子的协同作用来实现其对伤口愈合的促进作用。 Objective To study the effect of VEGF on the expression of KDR, bFGF and PDGF mRNA in the wounded tissue and elucidate the mechanisms of VEGF in promoting the wound healing. Methods A recombi nant expression vector of pcDNA3.1/myc-hisA-VEGF165,was constructed and transfected onto the wounded tissue by nanosphere.Expressions of KDR,bFGF and PDGF mRNA in the wounded tissue were detected by reverse tanscriptase PCR technique at 14th day after wounding. Results The growth speed of granulation tissue in nanosphere-VEGF165 complexes-treated group was obviously faster than that in saline-treated group.Reverse transcriptase PCR detected a significantly higher expression of KDR, bFGF and PDGF mRNA in the wounded tissues in nanosphere-VEGF165 complexes-treated group than that in saline-treated group (P < 0.05) and normal skin tissue (P < 0.01). Conclusion VEGF can upregulate the expression of KDR, bFGF and PDGF mRNA in wounded tissue.VEGF may act on its receptor KDR and play important role in promoting wound healing through its interaction with other cytokines.
出处 《中国美容医学》 CAS 2004年第3期266-268,共3页 Chinese Journal of Aesthetic Medicine
关键词 表达 血管内皮生长因子 基因治疗 纳米微囊 伤口愈合 vascular endothelial growth factor gene therapy nanosphere wound healing
  • 相关文献

参考文献6

  • 1贾宁,戴辉,毛海泉,陈苏民,易成刚,郭树忠.新型非病毒纳米微囊-VEGF复合体转染鼠成纤维细胞的体外试验研究[J].中国美容医学,2004,13(2):146-149. 被引量:9
  • 2Ohgoda O, Sakai A,Koga H,Kanai K, et al. Fibroblast-migration in a wound model of ascorbic acid-supplemented three-dimensional culture system:the effects of cytokines and malotilate,a new wound healing stimulant, on cell-migration [J].J Dermatol Sci,1998,
  • 3Corral CJ,Siddiqui A,Wu LC,et al.Vascular endothelial growth factors is more important than basic fibroblastic growth factor during ischemic wound healing[J].Arch Surg, 1999,134:200-205.
  • 4KW Leong,HQ Mao.DNA-polycation nanospheres as non -viral gene delivery vehicles[J].J Controlled Release, 1998,53:183 - 193.
  • 5Ferrara N, Gerber HP. The role of vascular endothelial growth factor in angiogenesis [J]. Acta Haematol, 2001,106:148-156.
  • 6Wu L,Pierce GF,Ladin DA,et al. Effects of oxygen on wound responses to growth factors:Kaposi's FGF,but not basic FGF-stimulates repair in ischemic wounds [J].Growth Factors, 1995,12:29-35.

二级参考文献17

  • 1[16]Davidoff AM, Leary MA, Ng CY, et al. Gene therapy-mediated expression by tumor cells of the angiogenesis inhibitor flk-1 results in inhibition of neuroblastoma growth in vivo [J].J Pediatr Surg, 2001, 36(1): 30~36.
  • 2[17]Enholm B, Karpanen, T, Jeltsch M, et al. Adenoviral expression of vascular endothelial growth factor-C induces lymphangiogenesis in the skin[J]. Circ Res,2001 ,88(6): 623~629.
  • 3[1]Jeanteur P. Heparanase cloned at last:a new target for an-timetastatic drugs (news) [J]. Bull Cancer, 1999, 86(9): 718.
  • 4[2]Ogawa K, Nakanishi H, TakeshitaF, et al. Establishment of rat hepatocellular carcinoma cell lines with differing metastatic potential in nude mice[J]. Iht J Cancer. 2001, 91(6): 797~802.
  • 5[3]Gohji K, Katsuoka Y, Okamoto M, et al. Human heparanase:roles in invasion and metastasis of cancer[J]. Hinyokika Kiyo,2000, 46(10): 757~762.
  • 6[4]Hulett MD,Homby JR,Ohms SJ,et al. Identification of active-site residues of the pro-metastatic endoglycosidase heparanase [J].Biochemistry, 2000,39(51): 15659~15667.
  • 7[5]Andela VB, Schwarz EM, Puzas JE, et al. Tumor metastasis and the reciprocal regulation of prometastatic and antimetastatic factors by nuclear factor kappaB[J]. Cancer Res,2000, 60(23):6557~6562.
  • 8[6]Leong KW,Mao HQ.DNA-polycation nanospheres as non -viral gene delivery vehicles[J].Controlled Release, 1998,53(1~3):183~193.
  • 9[7]Ltruong Le V,Mao HQ,Walsh S,et al. Delivery of DNA vaccine using gelation-DNA nanos-pheres,in:International Symposium on Controlled Release of Bioactive Materials 1997,Stockhoim,Sweden,Controlled Release Society,P.39.
  • 10[8]Cheng TL, Chen BM, Chern JW. et al.Efficient clearance of poly (ethylene glycol)-modified immunoenzyme with anti-PEG monoclonal antibody for prodrug cancer therapy [J]. Bioconjug Chem,2000, 11(2): 258~266.

共引文献8

同被引文献41

引证文献7

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部